MGNX logo

MacroGenics (MGNX) EBITDA

Annual EBITDA

$2.02 M
+$109.91 M+101.87%

December 31, 2023

Summary

Performance

1-Year Change

+101.87%

3-Year Change

+101.69%

5-Year Change

+101.24%

15-Year Change

+113.52%

MGNX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.89%
MGNX annual EBITDA is higher than 79.89% of companies in Healthcare sector

High & Low

All-time High

$9.16 M
MGNX annual EBITDA is currently -77.99% below its historical high of $9.16 million

3-Year Low

-$190.86 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MGNX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
MGNX next annual earnings announcement is scheduled for Mar 7, 2025

OtherMGNXprofitabilitymetrics:

Annual Revenue

$57.19 M
MGNX annual revenue is $57.19 million

Annual Net Income

-$9.06 M
MGNX annual net profit is -$9.06 million

Annual EBIT

-$7.63 M
MGNX annual earnings before interest & taxes is -$7.63 million

Annual EPS

-$0.15
MGNX annual earnings per share is -$0.15

Quarterly EBITDA

$58.14 M
+$111.99 M+207.98%

September 30, 2024

Summary

Performance

3-Month Change

+207.98%

1-Year Change

+231.63%

3-Year Change

+191.52%

5-Year Change

+191.52%

MGNX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.71%
MGNX quarterly EBITDA is higher than 87.71% of companies in Healthcare sector

High & Low

All-time High

$106.31 M
MGNX quarterly EBITDA is currently -45.31% below its historical high of $106.31 million

3-Year Low

-$63.53 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
MGNX next earnings announcement is scheduled for Mar 7, 2025

OtherMGNXprofitabilitymetrics:

Quarterly Revenue

$110.71 M
MGNX quarterly revenue is $110.71 million

Quarterly Net Income

$56.31 M
MGNX quarterly net profit is $56.31 million

Quarterly EBIT

$56.31 M
MGNX quarterly earnings before interest & taxes is $56.31 million

Quarterly EPS

$0.90
MGNX quarterly earnings per share is $0.90

TTM EBITDA

-$89.09 M
+$38.64 M+30.25%

September 30, 2024

Summary

Performance

3-Month Change

+30.25%

1-Year Change

-4517.01%

3-Year Change

+56.71%

5-Year Change

+56.71%

MGNX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

20.42%
MGNX TTM EBITDA is higher than 20.42% of companies in Healthcare sector

High & Low

All-time High

$62.22 M
MGNX TTM EBITDA is currently -243.18% below its historical high of $62.22 million

3-Year Low

-$206.75 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
MGNX next earnings announcement is scheduled for Mar 7, 2025

OtherMGNXprofitabilitymetrics:

TTM Revenue

$139.77 M
MGNX TTM revenue is $139.77 million

TTM Net Income

-$97.62 M
MGNX TTM net profit is -$97.62 million

TTM EBIT

-$96.48 M
MGNX TTM earnings before interest & taxes is -$96.48 million

TTM EPS

-$1.58
MGNX TTM earnings per share is -$1.58

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$2.02 M
MGNX annual EBITDA is $2.02 million

Annual Net Income

-$9.06 M
MGNX annual net profit is -$9.06 million

Annual Interest Expense

$1.43 M
MGNX annual interest expense is $1.43 million

Annual Income Tax

-
MGNX annual income tax value is unknown

Annual D&A

$9.64 M
MGNX annual depreciation & amortization is $9.64 million

MGNX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+101.9%+231.6%-4517.0%
3 y3 years+101.7%+191.5%+56.7%
5 y5 years+101.2%+191.5%+56.7%

MGNX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+101.1%-4.8%+191.5%-243.2%+56.9%
5 y5-yearat high+101.1%-4.8%+191.5%-243.2%+56.9%
alltimeall time-78.0%+101.1%-45.3%+191.5%-243.2%+56.9%

MacroGenics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$58.14 M(-208.0%)
-$89.09 M(-30.3%)
Jun 2024
-
-$53.85 M(+9.4%)
-$127.73 M(+895.6%)
Mar 2024
-
-$49.22 M(+11.4%)
-$12.83 M(-736.0%)
Dec 2023
$2.02 M(-101.9%)
-$44.17 M(-326.5%)
$2.02 M(-96.8%)
Sep 2023
-
$19.50 M(-68.1%)
$62.22 M(+199.9%)
Jun 2023
-
$61.05 M(-277.6%)
$20.75 M(-126.4%)
Mar 2023
-
-$34.37 M(-314.4%)
-$78.73 M(-27.0%)
Dec 2022
-$107.89 M(-43.5%)
$16.03 M(-173.0%)
-$107.89 M(-39.6%)
Sep 2022
-
-$21.97 M(-42.8%)
-$178.53 M(-13.7%)
Jun 2022
-
-$38.43 M(-39.5%)
-$206.75 M(+0.5%)
Mar 2022
-
-$63.53 M(+16.3%)
-$205.82 M(+7.8%)
Dec 2021
-$190.86 M(+60.2%)
-$54.60 M(+8.8%)
-$190.86 M(+40.8%)
Sep 2021
-
-$50.19 M(+33.8%)
-$135.53 M(+14.4%)
Jun 2021
-
-$37.50 M(-22.8%)
-$118.52 M(-5.4%)
Mar 2021
-
-$48.56 M(-6845.0%)
-$125.30 M(+5.2%)
Dec 2020
-$119.10 M(-27.8%)
$720.00 K(-102.2%)
-$119.10 M(-23.4%)
Sep 2020
-
-$33.17 M(-25.1%)
-$155.41 M(-1.1%)
Jun 2020
-
-$44.28 M(+4.5%)
-$157.12 M(-3.3%)
Mar 2020
-
-$42.37 M(+19.0%)
-$162.53 M(-1.4%)
Dec 2019
-$164.88 M(+1.7%)
-$35.59 M(+2.0%)
-$164.88 M(-1.3%)
Sep 2019
-
-$34.89 M(-29.8%)
-$167.08 M(+1.6%)
Jun 2019
-
-$49.69 M(+11.1%)
-$164.47 M(+4.2%)
Mar 2019
-
-$44.71 M(+18.3%)
-$157.89 M(-2.6%)
Dec 2018
-$162.05 M
-$37.79 M(+17.1%)
-$162.05 M(+802.8%)
Sep 2018
-
-$32.28 M(-25.1%)
-$17.95 M(-43.0%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$43.11 M(-11.8%)
-$31.49 M(+14.3%)
Mar 2018
-
-$48.87 M(-146.0%)
-$27.56 M(+84.8%)
Dec 2017
-$14.91 M(-71.6%)
$106.31 M(-332.0%)
-$14.91 M(-90.3%)
Sep 2017
-
-$45.82 M(+17.0%)
-$154.49 M(+9.7%)
Jun 2017
-
-$39.18 M(+8.1%)
-$140.86 M(+135.5%)
Mar 2017
-
-$36.23 M(+8.9%)
-$59.80 M(+14.1%)
Dec 2016
-$52.43 M(+202.8%)
-$33.26 M(+3.3%)
-$52.43 M(+12.6%)
Sep 2016
-
-$32.19 M(-176.9%)
-$46.56 M(+58.8%)
Jun 2016
-
$41.88 M(-245.1%)
-$29.32 M(-68.1%)
Mar 2016
-
-$28.86 M(+5.4%)
-$91.86 M(+430.4%)
Dec 2015
-$17.32 M(-52.5%)
-$27.39 M(+83.2%)
-$17.32 M(+105.1%)
Sep 2015
-
-$14.95 M(-27.6%)
-$8.44 M(-375.6%)
Jun 2015
-
-$20.65 M(-145.2%)
$3.06 M(-74.2%)
Mar 2015
-
$45.68 M(-346.7%)
$11.89 M(-132.6%)
Dec 2014
-$36.49 M(-2440.8%)
-$18.51 M(+437.3%)
-$36.49 M(+75.2%)
Sep 2014
-
-$3.45 M(-70.9%)
-$20.83 M(+110.3%)
Jun 2014
-
-$11.82 M(+336.3%)
-$9.90 M(-613.3%)
Mar 2014
-
-$2.71 M(-4.8%)
$1.93 M(+23.7%)
Dec 2013
$1.56 M(-83.0%)
-$2.85 M(-138.1%)
$1.56 M(-34.7%)
Sep 2013
-
$7.47 M(>+9900.0%)
$2.39 M(-206.0%)
Jun 2013
-
$11.80 K(-100.4%)
-$2.25 M(-0.5%)
Mar 2013
-
-$3.08 M(+52.5%)
-$2.26 M(-377.8%)
Dec 2012
$9.16 M(+43.3%)
-$2.02 M(-171.2%)
$815.20 K(-71.2%)
Sep 2012
-
$2.83 M
$2.83 M
Dec 2011
$6.40 M
-
-

FAQ

  • What is MacroGenics annual EBITDA?
  • What is the all time high annual EBITDA for MacroGenics?
  • What is MacroGenics annual EBITDA year-on-year change?
  • What is MacroGenics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for MacroGenics?
  • What is MacroGenics quarterly EBITDA year-on-year change?
  • What is MacroGenics TTM EBITDA?
  • What is the all time high TTM EBITDA for MacroGenics?
  • What is MacroGenics TTM EBITDA year-on-year change?

What is MacroGenics annual EBITDA?

The current annual EBITDA of MGNX is $2.02 M

What is the all time high annual EBITDA for MacroGenics?

MacroGenics all-time high annual EBITDA is $9.16 M

What is MacroGenics annual EBITDA year-on-year change?

Over the past year, MGNX annual EBITDA has changed by +$109.91 M (+101.87%)

What is MacroGenics quarterly EBITDA?

The current quarterly EBITDA of MGNX is $58.14 M

What is the all time high quarterly EBITDA for MacroGenics?

MacroGenics all-time high quarterly EBITDA is $106.31 M

What is MacroGenics quarterly EBITDA year-on-year change?

Over the past year, MGNX quarterly EBITDA has changed by +$102.32 M (+231.63%)

What is MacroGenics TTM EBITDA?

The current TTM EBITDA of MGNX is -$89.09 M

What is the all time high TTM EBITDA for MacroGenics?

MacroGenics all-time high TTM EBITDA is $62.22 M

What is MacroGenics TTM EBITDA year-on-year change?

Over the past year, MGNX TTM EBITDA has changed by -$91.11 M (-4517.01%)